Paroxetine Tablet, Film Coated
Product Images NDC 68788-8777

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68788-8777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Paroxetine Structural Formula (Image 01)

Chemical structure diagram of paroxetine hydrochloride hemihydrate showing molecular bonds and atoms with a fluorophenyl group, piperidine ring, and a dioxolane benzene ring system, including notation for hydrochloride and water hemihydrate components.*

FDA Label Image

Paroxetine HCl Tablets Usp 20mg (Image 03)

Paroxetine HCl Tablets USP 20 mg film-coated oral tablets label by Preferred Pharmaceuticals Inc. The label states the tablets contain paroxetine hydrochloride hemihydrate equivalent to 20 mg of paroxetine. The medication is noted as generic for Paxil, manufactured by Mylan Pharmaceuticals Inc. There are fields for lot number, batch number, expiration date, and quantity, as well as dosage instructions in English and Spanish on a yellow background. The label includes a caution against transfer of the drug to others.*

FDA Label Image

Figure 1. Impact Of Paroxetine On The Pharmacokinetics Of Co-administered Drugs (log Scale) (Image 06)

A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC parameters of various interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, Phenytoin 300 mg) relative to reference. The x-axis is a logarithmic scale from 0.1 to 10, depicting changes relative to reference values.*

FDA Label Image

Figure 2. Impact Of Co-administered Drugs On The Pharmacokinetics Of Paroxetine (Image 07)

A chart depicting the pharmacokinetic (PK) changes in Cmax and AUC for paroxetine when co-administered with various interacting drugs including cimetidine, phenobarbital, phenytoin, digoxin, and diazepam. The chart shows fold changes relative to a reference with 90% confidence intervals for each drug interaction.*

FDA Label Image

Figure 3. Impact Of Specific Population On The Pharmacokinetics Of Paroxetine (log Scale) (Image 08)

A chart showing fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax, AUC, Cmin) of paroxetine hydrochloride hemihydrate across different populations, including mild, moderate, and severe renal impairment, hepatic impairment, age groups over 65 years with varying doses, and male gender. The x-axis is labeled as change relative to reference on a logarithmic scale from 0.5 to 50.0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.